Gene Symbol: septin 10
Description: septin 10
Benedetti D, Bomben R, Dal Bo M, Marconi D, Zucchetto A, Degan M, et al
. Are surrogates of IGHV gene mutational status useful in B-cell chronic lymphocytic leukemia? The example of Septin-10. Leukemia. 2008;22:224-6 pubmed
Liu M, Shen S, Chen F, Yu W, Yu L. Linking the septin expression with carcinogenesis. Mol Biol Rep. 2010;37:3601-8 pubmed publisher
..These findings have contributed to the view that septins may belong to a kind of cancer critical genes. More septins might act as potential oncogenes or tumor suppressor genes in cancer development. ..
Lu Y, Ye Y, Bao W, Yang Q, Wang J, Liu Z, et al
. Genome-wide identification of genes essential for podocyte cytoskeletons based on single-cell RNA sequencing. Kidney Int. 2017;92:1119-1129 pubmed publisher
..Thus, the list of genes essential for podocyte cytoskeletons is expanded by single-cell RNA sequencing. It appears that podocyte-specific essential genes are mainly associated with podocyte cytoskeletons. ..
Xu M, Takanashi M, Oikawa K, Nishi H, Isaka K, Yoshimoto T, et al
. Identification of a novel role of Septin 10 in paclitaxel-resistance in cancers through a functional genomics screen. Cancer Sci. 2012;103:821-7 pubmed publisher
..We isolated two paclitaxel-resistant clones carrying the siRNA specific to septin 10 (SEPT10) and to budding uninhibited by benzimidazoles 3...
Macara I, Baldarelli R, Field C, Glotzer M, Hayashi Y, Hsu S, et al
. Mammalian septins nomenclature. Mol Biol Cell. 2002;13:4111-3 pubmed
..The human and mouse septin genes will be named SEPT1-SEPT10 and Sept1-Sept10, respectively. Splice variants will be designated by an underscore followed by a lowercase "v" and a number, e.g., SEPT4_v1. ..
Sui L, Zhang W, Liu Q, Chen T, Li N, Wan T, et al
. Cloning and functional characterization of human septin 10, a novel member of septin family cloned from dendritic cells. Biochem Biophys Res Commun. 2003;304:393-8 pubmed
..Here, we describe the identification of septin 10, a novel septin family member from human dendritic cells...
Morabito F, Cutrona G, Mosca L, D Anca M, Matis S, Gentile M, et al
. Surrogate molecular markers for IGHV mutational status in chronic lymphocytic leukemia for predicting time to first treatment. Leuk Res. 2015;39:840-5 pubmed publisher
..3, 95% CI: 1.1-4.9, P=.027) and MBOAT1 (HR=2.1, 95% CI: 1.1-3.7, P=.018) retained their independent prognostic impact, supporting the hypothesis that these genes may potentially act as surrogates for predicting IGHV mutational status. ..